Astrana Health (ASTH)
Astrana Health on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-management consulting services.
3.0M
Short interest
settlement 2026-10-15
8.8
Days to cover
+3.1 days vs prior
67.8%
Short share of volume
2026-11-02
5,979
Fails to deliver
settlement 2026-10-14
Thu 5 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ASTH is 3,010,140 shares, down 262,893 shares over the last month. Over the last 48 readings it ranged from 1,432,014 shares (30 June 2025) to 3,281,911 shares (31 August 2026). At the reported average volume of 340K shares a day that is 8.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/asth" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 3,010,140 | -2.5% | 340,295 | 8.85 |
| 2026-09-30 | 3,087,127 | -5.7% | 531,954 | 5.80 |
| 2026-09-15 | 3,273,033 | -0.3% | 279,499 | 11.71 |
| 2026-08-31 | 3,281,911 | +3.0% | 335,914 | 9.77 |
| 2026-08-14 | 3,184,849 | +12.6% | 567,219 | 5.61 |
| 2026-07-31 | 2,827,451 | +5.5% | 573,335 | 4.93 |
| 2026-07-15 | 2,679,220 | +0.2% | 685,812 | 3.91 |
| 2026-06-30 | 2,674,196 | +13.4% | 870,387 | 3.07 |
| 2026-06-15 | 2,357,167 | -1.7% | 521,593 | 4.52 |
| 2026-05-29 | 2,397,686 | -11.7% | 389,740 | 6.15 |
| 2026-05-15 | 2,715,952 | -5.1% | 534,143 | 5.08 |
| 2026-04-30 | 2,861,578 | +6.6% | 512,317 | 5.59 |
| 2026-04-15 | 2,684,891 | -6.4% | 373,089 | 7.20 |
| 2026-03-31 | 2,868,088 | +10.3% | 390,868 | 7.34 |
| 2026-03-13 | 2,599,392 | -11.1% | 712,918 | 3.65 |
| 2026-02-27 | 2,923,601 | +3.0% | 359,241 | 8.14 |
| 2026-02-13 | 2,838,645 | +10.7% | 603,639 | 4.70 |
| 2026-01-30 | 2,563,963 | +0.1% | 617,210 | 4.15 |
| 2026-01-15 | 2,560,764 | -7.0% | 484,679 | 5.28 |
| 2025-12-31 | 2,751,945 | -7.7% | 542,102 | 5.08 |
| 2025-12-15 | 2,982,920 | +25.3% | 494,597 | 6.03 |
| 2025-11-28 | 2,380,737 | -0.1% | 535,903 | 4.44 |
| 2025-11-14 | 2,383,376 | +18.6% | 736,583 | 3.24 |
| 2025-10-31 | 2,010,094 | +20.2% | 334,607 | 6.01 |
| 2025-10-15 | 1,672,266 | -3.2% | 261,269 | 6.40 |
| 2025-09-30 | 1,726,991 | +11.4% | 383,734 | 4.50 |
| 2025-09-15 | 1,549,683 | +0.5% | 340,600 | 4.55 |
| 2025-08-29 | 1,541,503 | -6.9% | 330,826 | 4.66 |
| 2025-08-15 | 1,656,150 | +3.1% | 632,283 | 2.62 |
| 2025-07-31 | 1,606,105 | +4.7% | 336,169 | 4.78 |
| 2025-07-15 | 1,533,915 | +7.1% | 255,020 | 6.01 |
| 2025-06-30 | 1,432,014 | -2.4% | 324,374 | 4.41 |
| 2025-06-13 | 1,466,471 | +1.9% | 198,377 | 7.39 |
| 2025-05-30 | 1,439,901 | -0.0% | 253,445 | 5.68 |
| 2025-05-15 | 1,440,398 | -7.1% | 327,104 | 4.40 |
| 2025-04-30 | 1,550,877 | +0.2% | 247,431 | 6.27 |
| 2025-04-15 | 1,548,411 | +6.3% | 330,847 | 4.68 |
| 2025-03-31 | 1,456,437 | -1.5% | 316,816 | 4.60 |
| 2025-03-14 | 1,479,228 | +2.7% | 412,702 | 3.58 |
| 2025-02-28 | 1,440,040 | -22.9% | 383,109 | 3.76 |
| 2025-02-14 | 1,866,664 | +11.4% | 237,788 | 7.85 |
| 2025-01-31 | 1,675,717 | +4.6% | 388,536 | 4.31 |
| 2025-01-15 | 1,601,815 | +7.5% | 389,234 | 4.12 |
| 2024-12-31 | 1,490,252 | -8.3% | 337,488 | 4.42 |
| 2024-12-13 | 1,625,760 | -0.8% | 241,024 | 6.75 |
| 2024-11-29 | 1,639,734 | +5.1% | 295,622 | 5.55 |
| 2024-11-15 | 1,559,765 | -18.0% | 413,881 | 3.77 |
| 2024-10-31 | 1,901,453 | -12.9% | 192,411 | 9.88 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of ASTH volume is 67.8%, up 1.8 points over the last five sessions. Over the last 30 readings it ranged from 43.9% (14 October 2026) to 86.4% (30 September 2026). The latest reading is 4.8 points below the 30-session average of 72.5%, on 98K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 66K | 98K | 67.8% | 13 |
| 2026-10-30 | 50K | 69K | 72.2% | 3 |
| 2026-10-29 | 65K | 84K | 77.8% | 0 |
| 2026-10-28 | 62K | 89K | 69.3% | 0 |
| 2026-10-27 | 75K | 98K | 76.1% | 0 |
| 2026-10-26 | 37K | 56K | 66.0% | 0 |
| 2026-10-23 | 47K | 61K | 76.8% | 199 |
| 2026-10-22 | 39K | 55K | 70.9% | 0 |
| 2026-10-21 | 57K | 72K | 79.4% | 0 |
| 2026-10-20 | 53K | 72K | 73.5% | 0 |
| 2026-10-19 | 64K | 96K | 67.4% | 0 |
| 2026-10-16 | 44K | 72K | 61.0% | 5 |
| 2026-10-15 | 43K | 86K | 49.9% | 12 |
| 2026-10-14 | 74K | 169K | 43.9% | 1,300 |
| 2026-10-13 | 72K | 85K | 84.4% | 0 |
| 2026-10-12 | 55K | 79K | 69.1% | 0 |
| 2026-10-09 | 76K | 93K | 81.0% | 0 |
| 2026-10-08 | 63K | 110K | 57.0% | 0 |
| 2026-10-07 | 57K | 90K | 62.6% | 0 |
| 2026-10-06 | 59K | 75K | 78.3% | 0 |
| 2026-10-05 | 107K | 125K | 85.0% | 0 |
| 2026-10-02 | 105K | 132K | 80.2% | 0 |
| 2026-10-01 | 50K | 72K | 69.7% | 0 |
| 2026-09-30 | 76K | 88K | 86.4% | 0 |
| 2026-09-29 | 63K | 84K | 74.5% | 0 |
| 2026-09-28 | 101K | 126K | 80.3% | 0 |
| 2026-09-25 | 81K | 106K | 76.6% | 12 |
| 2026-09-24 | 91K | 121K | 74.8% | 0 |
| 2026-09-23 | 117K | 145K | 81.3% | 0 |
| 2026-09-22 | 107K | 130K | 82.7% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in ASTH is 5,979 shares, up 5,407 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (12 May 2026) to 30,861 shares (16 September 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 5,979 | $37.87 | $226K |
| 2026-10-09 | 572 | $35.87 | $21K |
| 2026-10-07 | 51 | $37.00 | $2K |
| 2026-09-29 | 2,319 | $35.13 | $81K |
| 2026-09-16 | 30,861 | $38.35 | $1.2M |
| 2026-09-08 | 755 | $38.47 | $29K |
| 2026-09-04 | 348 | $37.83 | $13K |
| 2026-09-02 | 104 | $38.60 | $4K |
| 2026-08-28 | 15 | $38.41 | $576 |
| 2026-08-19 | 12 | $39.16 | $470 |
| 2026-08-18 | 976 | $39.75 | $39K |
| 2026-08-06 | 1,083 | $35.83 | $39K |
| 2026-07-24 | 287 | $40.99 | $12K |
| 2026-07-22 | 1,698 | $45.46 | $77K |
| 2026-07-20 | 146 | $44.94 | $7K |
| 2026-07-16 | 34 | $47.04 | $2K |
| 2026-07-14 | 365 | $47.64 | $17K |
| 2026-07-06 | 100 | $49.17 | $5K |
| 2026-07-02 | 2,077 | $49.81 | $103K |
| 2026-07-01 | 4,737 | $46.41 | $220K |
| 2026-06-18 | 25 | $38.16 | $954 |
| 2026-06-11 | 736 | $38.73 | $29K |
| 2026-06-02 | 51 | $37.76 | $2K |
| 2026-05-22 | 4 | $37.38 | $150 |
| 2026-05-15 | 313 | $39.16 | $12K |
| 2026-05-12 | 1 | $37.97 | $38 |
| 2026-05-11 | 92 | $39.30 | $4K |
| 2026-03-30 | 200 | $24.19 | $5K |
| 2026-03-23 | 4,392 | $24.23 | $106K |
| 2026-03-19 | 2,248 | $24.49 | $55K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for ASTH in the last 90 days. The most recent filings are listed below. Latest filing: Vong John (SVP - Accounting (PAO)) on 2026-10-10.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-10 | Vong John | SVP - Accounting (PAO) | Tax withholding | 556 | $37.55 | $21K | 22K |
| 2026-10-06 | Sim Brandon | CEO and President | Tax withholding | 10K | $37.00 | $366K | 1.2M |
| 2026-10-06 | Lam Thomas S. | Director | Tax withholding | 3K | $37.00 | $97K | 463K |
| 2026-10-02 | Basho Chandan | COO and CFO | Tax withholding | 2K | $35.88 | $75K | 156K |
| 2026-09-15 | Vong John | SVP - Accounting (PAO) | Tax withholding | 96 | $38.35 | $4K | 22K |
| 2026-09-05 | Sim Brandon | CEO and President | Tax withholding | 7K | $38.47 | $276K | 1.2M |
| 2026-09-05 | Basho Chandan | COO and CFO | Tax withholding | 2K | $38.47 | $69K | 158K |
| 2026-08-31 | Kitayama Mitchell W | Director | Returned to company | 9K | $37.09 | $315K | 24K |
| 2026-08-14 | Schmidt David | Director | Returned to company | 20K | $38.59 | $772K | 36K |
| 2026-08-14 | Schmidt David | Director | Exercise or conversion | 20K | $5.00 | $100K | 56K |
| 2026-08-07 | Sobotka Glenn | Former Officer | Returned to company | 12K | $0.00 | $0 | 2K |
| 2026-06-27 | Sim Brandon | CEO and President | Tax withholding | 1K | $44.51 | $49K | 1.2M |
| 2026-06-10 | Schmidt David | Director | Grant | 5K | $0.00 | $0 | 36K |
| 2026-06-10 | Mazdyasni Matthew | Director | Grant | 5K | $0.00 | $0 | 39K |
| 2026-06-10 | Kitayama Mitchell W | Director | Grant | 5K | $0.00 | $0 | 33K |
| 2026-06-10 | Dong Linda | Director | Grant | 5K | $0.00 | $0 | 97K |
| 2026-06-10 | Dai, Weili | Director | Grant | 5K | $0.00 | $0 | 18K |
| 2026-06-10 | Chiang John | Director | Grant | 5K | $0.00 | $0 | 35K |
| 2026-05-16 | Basho Chandan | COO and CFO | Tax withholding | 8K | $38.26 | $312K | 160K |
| 2026-04-14 | Basho Chandan | COO and CFO | Tax withholding | 4K | $29.07 | $113K | 168K |
| 2026-04-06 | Lam Thomas S. | Director | Grant | 42K | $0.00 | $0 | 466K |
| 2026-04-06 | Sim Kenneth T. | Executive Chairman | Grant | 100K | $0.00 | $0 | 739K |
| 2026-04-06 | Sim Brandon | CEO and President | Grant | 201K | $0.00 | $0 | 1.2M |
| 2026-04-02 | Basho Chandan | COO and CFO | Tax withholding | 2K | $25.05 | $52K | 172K |
| 2026-04-01 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 58K | $24.51 | $1.4M | 178K |
| 2026-04-01 | Kumar Dinesh M. | Chief Medical Officer | Grant | 35K | $0.00 | $0 | 236K |
| 2026-03-26 | Sobotka Glenn | Chief Accounting Officer | Tax withholding | 662 | $24.27 | $16K | 14K |
| 2026-03-05 | Lam Thomas S. | Director | Tax withholding | 9K | $25.07 | $232K | 424K |
| 2026-03-05 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 2K | $25.07 | $43K | 200K |
| 2026-03-05 | Basho Chandan | COO and CFO | Tax withholding | 1K | $25.07 | $31K | 174K |
| 2026-02-02 | Sim Brandon | CEO and President | Exercise or conversion | 21K | $23.24 | $496K | 1.0M |
| 2026-01-23 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 11K | $27.16 | $292K | 202K |
| 2026-01-13 | Schmidt David | Director | Tax withholding | 4K | $27.12 | $116K | 31K |
| 2026-01-13 | Schmidt David | Director | Exercise or conversion | 20K | $5.79 | $116K | 36K |
| 2026-01-01 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 5K | $24.81 | $127K | 213K |
| 2025-12-08 | Lam Thomas S. | Director | Tax withholding | 26K | $22.00 | $569K | 433K |
| 2025-12-08 | Lam Thomas S. | Director | Exercise or conversion | 30K | $17.78 | $525K | 459K |
| 2025-11-10 | Mazdyasni Matthew | Director | Exercise or conversion | 20K | $18.20 | $364K | 35K |
| 2025-11-10 | Sim Kenneth T. | Executive Chairman | Exercise or conversion | 30K | $17.78 | $525K | 639K |
| 2025-11-07 | Kitayama Mitchell W | Director | Exercise or conversion | 12K | $18.20 | $218K | 28K |
| 2025-11-03 | Marsh Linda | Director | Tax withholding | 11K | $32.99 | $364K | 93K |
| 2025-11-03 | Marsh Linda | Director | Exercise or conversion | 20K | $18.20 | $364K | 104K |
| 2025-10-02 | Basho Chandan | COO and CFO | Tax withholding | 2K | $27.77 | $55K | 175K |
| 2025-09-15 | Kitayama Mitchell W | Director | Returned to company | 5K | $30.23 | $158K | 16K |
| 2025-09-15 | Kitayama Mitchell W | Director | Returned to company | 8K | $30.23 | $242K | 21K |
| 2025-09-15 | Kitayama Mitchell W | Director | Exercise or conversion | 8K | $18.20 | $146K | 29K |
| 2025-09-05 | Basho Chandan | COO and CFO | Tax withholding | 2K | $29.70 | $50K | 177K |
| 2025-09-05 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 2K | $29.70 | $50K | 218K |
| 2025-09-02 | Schmidt David | Director | Returned to company | 20K | $27.76 | $555K | 16K |
| 2025-09-02 | Schmidt David | Director | Exercise or conversion | 20K | $18.20 | $364K | 36K |
| 2025-08-13 | Chiang John | Director | Tax withholding | 12K | $29.63 | $364K | 31K |
| 2025-08-13 | Chiang John | Director | Exercise or conversion | 20K | $18.20 | $364K | 43K |
| 2025-07-01 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 7K | $25.06 | $171K | 219K |
| 2025-06-11 | Mazdyasni Matthew | Director | Grant | 6K | $0.00 | $0 | 15K |
| 2025-06-11 | Marsh Linda | Director | Grant | 6K | $0.00 | $0 | 84K |
| 2025-06-11 | Kitayama Mitchell W | Director | Grant | 6K | $0.00 | $0 | 21K |
| 2025-06-11 | Dai, Weili | Director | Grant | 6K | $0.00 | $0 | 14K |
| 2025-06-11 | Chiang John | Director | Grant | 6K | $0.00 | $0 | 23K |
| 2025-06-11 | Schmidt David | Director | Grant | 6K | $0.00 | $0 | 16K |
| 2025-06-04 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 2K | $25.06 | $41K | 226K |
| 2025-05-16 | Basho Chandan | COO and CFO | Tax withholding | 10K | $27.18 | $273K | 179K |
| 2025-04-29 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 828 | $31.15 | $26K | 227K |
| 2025-04-14 | Basho Chandan | COO and CFO | Tax withholding | 3K | $34.05 | $91K | 189K |
| 2025-04-02 | Basho Chandan | COO and CFO | Tax withholding | 1K | $30.02 | $42K | 191K |
| 2025-03-26 | Sobotka Glenn | Chief Accounting Officer | Grant | 6K | $0.00 | $0 | 6K |
| 2025-03-26 | Sobotka Glenn | Chief Accounting Officer | Grant | 8K | $0.00 | $0 | 15K |
| 2025-03-05 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 8K | $27.19 | $214K | 228K |
| 2025-03-05 | Kumar Dinesh M. | Chief Medical Officer | Grant | 27K | $0.00 | $0 | 236K |
| 2025-03-05 | Lam Thomas S. | Director | Tax withholding | 9K | $27.19 | $251K | 430K |
| 2025-03-05 | Basho Chandan | COO and CFO | Grant | 27K | $0.00 | $0 | 193K |
| 2025-03-05 | Sim Brandon | CEO and President | Tax withholding | 106K | $27.19 | $2.9M | 1.0M |
| 2025-03-05 | Sim Brandon | CEO and President | Grant | 146K | $0.00 | $0 | 1.1M |
| 2025-02-15 | Lam Thomas S. | Director | Other transaction | 700K | $0.00 | $0 | 6.1M |
| 2025-02-15 | Lam Thomas S. | Director | Other transaction | 26K | $0.00 | $0 | 1.1M |
| 2025-02-15 | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | TenPercentOwner | Other transaction | 700K | $0.00 | $0 | 6.1M |
| 2025-02-15 | Sim Kenneth T. | Executive Chairman | Other transaction | 700K | $0.00 | $0 | 6.1M |
| 2025-02-15 | Sim Kenneth T. | Executive Chairman | Other transaction | 26K | $0.00 | $0 | 546K |
| 2025-01-23 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 7K | $37.96 | $274K | 209K |
| 2025-01-17 | Sim Kenneth T. | Executive Chairman | Returned to company | 300K | $35.17 | $10.6M | 6.8M |
| 2025-01-01 | Kumar Dinesh M. | Chief Medical Officer | Tax withholding | 967 | $31.53 | $30K | 216K |
| 2024-12-10 | Kitayama Mitchell W | Director | Returned to company | 5K | $43.09 | $220K | 15K |
| 2024-11-30 | Vong John | Chief Accounting Officer | Tax withholding | 134 | $43.25 | $6K | 18K |
| 2024-11-22 | Kitayama Mitchell W | Director | Exercise or conversion | 3K | $18.41 | $63K | 21K |
| 2024-11-22 | Kitayama Mitchell W | Director | Tax withholding | 1K | $42.11 | $63K | 20K |
| 2024-11-19 | Chiang John | Director | Tax withholding | 681 | $40.93 | $28K | 17K |
| 2024-11-19 | Chiang John | Director | Exercise or conversion | 2K | $18.41 | $28K | 17K |
| 2024-11-18 | Sim Kenneth T. | Executive Chairman | Exercise or conversion | 28K | $18.65 | $523K | 610K |
| 2024-11-12 | Vong John | Chief Accounting Officer | Tax withholding | 636 | $42.91 | $27K | 18K |
| 2024-11-08 | Sim Kenneth T. | Executive Chairman | Grant | 133K | $0.00 | $0 | 582K |
| 2024-11-08 | Sim Kenneth T. | Executive Chairman | Grant | 67K | $0.00 | $0 | 449K |
| 2024-11-08 | Lam Thomas S. | Director | Grant | 27K | $0.00 | $0 | 439K |
| 2024-11-08 | Lam Thomas S. | Director | Grant | 13K | $0.00 | $0 | 412K |
| 2024-11-08 | Sim Brandon | CEO and President | Grant | 34K | $0.00 | $0 | 983K |
| 2024-11-08 | Basho Chandan | COO and CFO | Tax withholding | 691 | $46.96 | $32K | 166K |
| 2024-11-08 | Basho Chandan | COO and CFO | Grant | 16K | $0.00 | $0 | 167K |
| 2024-11-08 | Kumar Dinesh M. | See remarks | Grant | 67K | $0.00 | $0 | 217K |
| 2024-10-02 | Sim Brandon | CEO and President | Tax withholding | 3K | $57.87 | $152K | 949K |
| 2024-09-10 | Kitayama Mitchell W | Director | Tax withholding | 4K | $47.93 | $169K | 18K |
| 2024-09-10 | Kitayama Mitchell W | Director | Exercise or conversion | 11K | $15.35 | $169K | 21K |
| 2024-09-10 | Marsh Linda | Director | Exercise or conversion | 11K | $15.35 | $169K | 81K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSONNo holder on file reports 5% or more of ASTH in its latest filing.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-30 | 13G/Ano. 1 | Vanguard Portfolio Managementinvestment adviser | 2.6M | 4.7% | 2026-09-30 |
| 2026-03-26 | 13G/Ano. 5 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding ASTH at their latest 13F. JSON4 of the 30 tracked managers held ASTH at their latest 13F, $14.3M in total at quarter-end prices. Millennium Management is the largest at $8.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 191K | $8.8M | 0.00% | +175K |
| Renaissance Technologies | 2026-06-30 | 75K | $3.5M | 0.00% | -30K |
| Citadel Advisors | 2026-06-30 | 25K | $1.2M | 0.00% | +50 |
| AQR Capital Management | 2026-06-30 | 18K | $818K | 0.00% | -17K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Astrana Health in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Astrana Health (ASTH), SEC CIK 1083446, listed on Nasdaq, classified by the SEC as services-management consulting services. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-30.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-10.JSON and CSV
- Company record
- EDGAR filing index for CIK 1083446Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-management consulting services
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of ASTH is sold short?
3,010,140 shares were held short at the 2026-10-15 settlement, 8.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ASTH's daily short volume?
On 2026-11-02, 66,218 of the 97,720 ASTH shares reported to FINRA were sold short, 67.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ASTH have fails to deliver?
The SEC's latest file shows 5,979 ASTH shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are ASTH insiders buying or selling?
No open-market insider trades were reported for ASTH in the last 90 days. The most recent filings are listed below. Latest filing: Vong John (SVP - Accounting (PAO)) on 2026-10-10.
Who owns 5% or more of ASTH?
No holder on file reports 5% or more of ASTH in its latest filing.
Which tracked 13F managers own ASTH?
4 of the 30 tracked 13F managers held ASTH shares at their latest filing, $14.3M in all. The largest: Izzy Englander's Millennium Management (191K shares, $8.8M), Renaissance Technologies (75K shares, $3.5M), Ken Griffin's Citadel Advisors (25K shares, $1.2M), Cliff Asness's AQR Capital Management (18K shares, $818K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.